Immunotherapy for Lung Cancer: Currently Enrolling Clinical Trials of Combination Therapies
Article
Immunotherapy Forum Video #25: In Part 2 of 2 videos, Dr.
Using Non/Off-Targeted Therapies in Targeted Lung Cancer Populations
Article
Acquired Resistance Forum Video #6: Dr. Nate Pennell of the Cleveland Clinic discussed the other options available to patients with ALK, ROS1 and EGFR lung cancer, such as chemotherapy, Avastin, and immunotherapy.
[powerpress]
Does Adding Avastin to Tarceva Help EGFR Positive Lung Cancer Patients?
Article
Drs. Nasser Hanna, Melissa Johnson and Jack West discuss results of a phase 2 trial presented at ASCO 2014 that studied if adding Avastin (bevicizumab) to Tarceva helped EGFR positive lung cancer patients increase progression-free survival. June 2014.
[powerpress]
